Xenograft mouse model studies showed that 5-8F nasopharyngeal carcinoma cells [63], hepatocellular carcinoma cell line Huh7 [64], and human glioblastoma cell line A172 [65] expressing nestin shRNA yielded decreased tumor volume compared to those from control cells (Table 1). This evidence concerns the gene NES and hepatocellular carcinoma.